Advancements in Handheld Capnography Equipment Drive Capnography Equipment Market in APAC
Existing CO2 measurement devices, including arterialized capillary blood gas, arterial blood gas, and venous blood gas analysis devices, are considered a gold standard in clinical practices. However, these devices are invasive and require the recurrent collection of blood samples for CO2 measurement, which may cause pain and discomfort among patients and unexpected blood loss. Moreover, these are time-consuming procedures that specifically require expertise and skills. As the conventional CO2 measuring techniques can go on for a long span, they inflict damage to tissue, nerves, and vessels. In contrast, handheld capnography instruments are easier to use than their conventional counterparts, and they can also be used in home care settings. Therefore, key companies are focused on developing portable/point-of-care or handheld capnography equipment for use in applications that require easy device mobility and patient access. Capnocheck II Hand-Held Capnograph/Oximeter/CO2 Detector by Smiths Group Plc, Microcap Handheld Capnographs by Medtronic Plc, and EMMA Capnograph and EMMA Mainstream Capnometer by Masimo Corporation are a few examples of handheld capnography equipment available in the market.
Market Overview
Asia Pacific (APAC) is the fastest-growing regional market for capnography equipment. The capnography equipment market in Asia Pacific is segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC. The region accounted for 8.1% share of the global market in 2021. The rising prevalence of benign prostatic hyperplasia amongst men along with increasing risk factors, surging demand for minimally invasive treatment in the region, and the growing prevalence of obesity in the region propel the Asia Pacific capnography equipment market growth. China dominated the regional market. The capnography equipment market in China is expected to expand during the forecast period owing to the increasing prevalence of COPD in the country and the surging number of surgeries. For instance, according to the data published in Journal of Thoracic Diseases in China, COPD is increasingly becoming a cause of public health concern and ranks first among the causes of disability. Moreover, in 2018, the overall prevalence rate of COPD in China is 8.2% and mortality rate because of the disease is ~1.6%. COPD is reported to be the fourth leading cause of death in rural areas, with a prevalence rate of 4.4% to 16.7%. Therefore, the growing prevalence of COPD is fueling the growth of the capnography market in China.
Strategic insights for the Asia-Pacific Capnography Equipment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the Asia-Pacific Capnography Equipment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.Asia-Pacific Capnography Equipment Strategic Insights
Asia-Pacific Capnography Equipment Report Scope
Report Attribute
Details
Market size in 2022
US$ 98.35 Million
Market Size by 2028
US$ 150.94 Million
Global CAGR (2022 - 2028)
7.4%
Historical Data
2020-2021
Forecast period
2023-2028
Segments Covered
By Product Type
By Technology
By Application
By End User
Regions and Countries Covered
Asia-Pacific
Market leaders and key company profiles
Asia-Pacific Capnography Equipment Regional Insights
APAC Capnography Equipment Market Segmentation
The asia pacific capnography equipment market is segmented into product type, technology, application, end user and country. Based on product type, the market is segmented into capnometer and capnography accessories & disposables. The capnography accessories & disposables segment registered a larger market share in 2022.
Based on technology, the APAC capnography equipment market is segmented into mainstream capnography, sidestream capnography, and microstream capnography. The mainstream capnography segment registered the largest market share in 2022. Based on application, the APAC capnography equipment market is segmented into cardiac care, trauma and emergency care, procedural sedation, respiratory monitoring, and others. The cardiac care segment registered the largest market share in 2022. Based on end user, the APAC capnography equipment market is segmented into hospitals, ambulatory surgery center, home care settings, and others. The hospitals segment registered the largest market share in 2022. Based on country, the APAC capnography equipment market is segmented into Australia, China, India, Japan, South Korea, and the Rest of APAC. China dominated the market share in 2022. BD, Dragerwerk AG & Co. KGaA, General Electric Company, Hill Rom Holding Inc. (Baxter), ICU Medical Inc., Koninklijke Philips N.V., Masimo, Medtronic, Nihon Kohden Corporation, and SCHILLER Americas Inc. are among the leading companies operating in the capnography equipment market in the region.
The Asia-Pacific Capnography Equipment Market is valued at US$ 98.35 Million in 2022, it is projected to reach US$ 150.94 Million by 2028.
As per our report Asia-Pacific Capnography Equipment Market, the market size is valued at US$ 98.35 Million in 2022, projecting it to reach US$ 150.94 Million by 2028. This translates to a CAGR of approximately 7.4% during the forecast period.
The Asia-Pacific Capnography Equipment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia-Pacific Capnography Equipment Market report:
The Asia-Pacific Capnography Equipment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia-Pacific Capnography Equipment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia-Pacific Capnography Equipment Market value chain can benefit from the information contained in a comprehensive market report.